New York State Common Retirement Fund’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-34,594
| Closed | -$2.5M | – | 3172 |
|
|
2025
Q4 | $2.5M | Sell |
34,594
-358,050
| -91% | -$23.1M | ﹤0.01% | 1314 |
|
|
2025
Q3 | $17.1M | Buy |
392,644
+120,365
| +44% | +$4.87M | 0.02% | 514 |
|
|
2025
Q2 | $7.73M | Hold |
272,279
| – | – | 0.01% | 870 |
|
|
2025
Q1 | $8.04M | Buy |
272,279
+87,468
| +47% | +$2.72M | 0.01% | 813 |
|
|
2024
Q4 | $5.37M | Buy |
184,811
+598
| +0.3% | +$25K | 0.01% | 1072 |
|
|
2024
Q3 | $8.46M | Buy |
184,213
+63,843
| +53% | +$2.77M | 0.01% | 865 |
|
|
2024
Q2 | $4.92M | Sell |
120,370
-863
| -0.7% | -$24.8K | 0.01% | 1135 |
|
|
2024
Q1 | $3.09M | Buy |
121,233
+16,228
| +15% | +$254K | ﹤0.01% | 1300 |
|
|
2023
Q4 | $950K | Sell |
105,005
-144
| -0.1% | -$963 | ﹤0.01% | 1818 |
|
|
2023
Q3 | $671K | Buy |
105,149
+261
| +0.2% | +$2.25K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $1.16M | Sell |
104,888
-43
| -0% | -$539 | ﹤0.01% | 1702 |
|
|
2023
Q1 | $1.61M | Buy |
104,931
+20,337
| +24% | +$447K | ﹤0.01% | 1641 |
|
|
2022
Q4 | $1.88M | Buy |
84,594
+34,857
| +70% | +$520K | ﹤0.01% | 1674 |
|
|
2022
Q3 | $812K | Buy |
49,737
+165
| +0.3% | +$3.16K | ﹤0.01% | 2073 |
|
|
2022
Q2 | $720K | Buy |
49,572
+21,240
| +75% | +$316K | ﹤0.01% | 2179 |
|
|
2022
Q1 | $523K | Buy |
28,332
+9
| +0% | +$153 | ﹤0.01% | 2389 |
|
|
2021
Q4 | $673K | Buy |
28,323
+4,712
| +20% | +$113K | ﹤0.01% | 2282 |
|
|
2021
Q3 | $582K | Sell |
23,611
-4,041
| -15% | -$87.8K | ﹤0.01% | 2378 |
|
|
2021
Q2 | $683K | Buy |
27,652
+4,752
| +21% | +$111K | ﹤0.01% | 2414 |
|
|
2021
Q1 | $499K | Buy |
22,900
+7,700
| +51% | +$188K | ﹤0.01% | 2463 |
|
|
2020
Q4 | $388K | Buy |
15,200
+7,600
| +100% | +$222K | ﹤0.01% | 2472 |
|
|
2020
Q3 | $214K | Buy |
+7,600
| New | +$220K | ﹤0.01% | 2613 |
|
Other funds holding RNAM
New York State Common Retirement Fund's RNAM Position: Q1 2026 in Review
New York State Common Retirement Fund sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 34,594 shares — an estimated $2.5M sold.
New York State Common Retirement Fund first reported a position in RNAM in Q3 2020 and held it in 22 quarters. The position peaked at $17.1M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- New York State Common Retirement Fund reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 34,594 Avidity Biosciences shares in Q1 2026, an estimated $2.5M.
- New York State Common Retirement Fund first reported a position in Avidity Biosciences in Q3 2020 and held it in 22 quarters.
- New York State Common Retirement Fund's Avidity Biosciences position peaked at $17.1M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.